Evogene (EVGN) – Press Releases
-
Evogene Announces Filing of Annual Report on Form 20-F
-
Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification
-
Bayer AG and Lavie Bio Continue for Second Year of Biofungicides Validation Following Successful Lab and Greenhouse Testing
-
Lavie Bio and Ceres Global Ag Corp. Collaborate to Include YalosTM Bio-Inoculant, in Regenerative Agriculture Initiatives in North America
-
Evogene Reports Fourth Quarter and Full Year 2023 Financial Results
-
AgPlenus Achieves Milestone in Collaboration with Corteva to Develop Novel Herbicides
-
EverGen Infrastructure Announces Record Single-Day and Monthly Gas Production at the Fraser Valley Biogas Facility
-
Casterra Announces New Agreements with Seed Producers in Brazil and Africa to Meet Growing Demand for its Elite Castor Seed Varieties
-
Lavie Bio Successfully Secures Second Half Advance Payment of $2.5M after Meeting Corteva's Licensing Agreement Requirements
-
Evogene Schedules Fourth Quarter 2023 Financial Results Release & Conference Call for March 7th, 2024
-
AgPlenus Announces Appointment of Dr. Dan Jacob Gelvan as its Incoming Chief Executive Officer
-
AgPlenus Announces Licensing & Collaboration Agreement with Bayer to Develop a New Sustainable Weed Control Solution
-
Syngenta and Lavie Bio Announce Partnership to Discover and Develop Novel Bio-Insecticide
-
Evogene and Verb Biotics Enter Collaboration Agreement to Advance Probiotic Innovation
-
EverGen Infrastructure Announces Issuance of Shares to the Company’s Board of Directors
-
Biomica CEO Set to Engage in Panel Discussion at 8th Annual European Microbiome Movement Summit
-
Biomica Successfully Completes Phase I Trial Enrollment for Microbiome-Based Immuno-Oncology Drug
-
EverGen Infrastructure Announces Completion of the Fraser Valley Biogas Expansion and Delivery of First Gas
-
Biomica CEO Set to Attend JP Morgan Healthcare Week in San Francisco, January 8-11, 2024
-
Casterra Appoints New CEO and Expands Team to Drive Growth and Innovation
-
Lavie Bio Announces a Distribution Agreement with WinField United Canada for its Bio-Inoculant Seed Treatment Yalos™
-
EverGen Infrastructure Announces Award of 5-Year Compostable Waste Processing Agreement with the City of Abbotsford
-
Lavie Bio Announces Expansion of its Bio-Inoculant Product for Spring Wheat, Yalos™, to Durum and Barley
-
EverGen Infrastructure Reports Q3 2023 Results
-
EverGen Infrastructure Announces Dates for 2023 Third Quarter Financial Results and Conference Call
-
Evogene Reports Third Quarter 2023 Financial Results
-
Lavie Bio Reports Advancement in Bio-Fungicide Program Against Downy Mildew with 2023 Field Trial Results
-
EverGen Infrastructure Secures 10-Year Offtake Agreement at GrowTEC Facility in Alberta
-
Evogene Schedules Third Quarter 2023 Financial Results Release & Conference Call for November 15, 2023
-
Colors Farm, Evogene and Ben-Gurion University Collaborate to Establish Crustacean Gene Editing Technology
-
EverGen Infrastructure Announces Mechanical Completion at Fraser Valley Biogas
-
Evogene Provides Operational Update Amidst Current Security Situation in Israel
-
EverGen Infrastructure Announces 10-Year Organic Waste Processing Agreement with the City of Regina and $7 Million Senior Term Loan with Business Development Bank of Canada
-
CORRECTING and REPLACING EverGen Infrastructure Announces 10-Year Organic Waste Processing Agreement with the City of Regina and $7 Million Senior Term Loan with Business Development Bank of Canada
-
Casterra Delivers First Shipment of Castor Seeds to Africa
-
EverGen Infrastructure Announces CEO Transition, Names Ford Nicholson as Interim Executive Chair and Mischa Zajtmann as Interim CEO
-
EverGen Infrastructure Reports Q2 2023 Results
-
EverGen Infrastructure Announces Dates for 2023 Second Quarter Financial Results and Conference Call
-
Evogene Reports Second Quarter 2023 Financial Results
-
Biomica Opens Second Site to Advance Its Immuno-Oncology Drug Trials at Davidoff Center
-
Evogene Schedules Second Quarter 2023 Financial Results Release & Conference Call for August 17, 2023
-
Evogene's ChemPass AI Tech-Engine is Introduced with New Breakthrough Machine Learning Technology for Target-Protein Discovery
-
Biomica Announces Interim Positive Results from Pre-Clinical Studies in its Irritable Bowel Syndrome (IBS) Program
-
EverGen Infrastructure Announces First RNG Injection at GrowTEC
-
Evogene Announces Pricing of US$8,500,000 Registered Direct Offering
-
Lavie Bio Announces Licensing Agreement for Bio-Fungicides with Corteva Agriscience
-
AgPlenus Appoints Dr. Adrian Percy to Its Board of Directors
-
Casterra Announces Additional $2.2 Million of Purchase Orders to Supply Castor Seeds for New African Territories
-
EverGen Infrastructure Provides Construction Update at Fraser Valley Biogas & Announces Drawdown of Initial $15 Million Tranche of $31 Million Senior Term Loan Facility
-
EverGen Infrastructure Awarded $10.5M in Funding from the Natural Resources Canada’s Clean Fuels Fund
Back to EVGN Stock Lookup